NASDAQ: SOTK
SONO TEK CORPCIK 0000806172 · SIC 3559 · Special Industry Machinery NEC
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (HPQ 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade SOTK commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
revenue $20.9M, net income $1.8M. Sono-Tek posts record revenue, 42% profit jump; medical rebounds, clean energy slumps
5 material changes detected. Sign up free to read the summary.
Sono-Tek reports fiscal 2026 full-year financial results
2 material changes detected. Sign up free to read the summary.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Jul 8, 2026 (period ending May 31, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Income (Unaudited)
| Description | Three months ended May 31, 2026 | Three months ended May 31, 2025 |
|---|---|---|
| Net Sales | 5,661,159 | 5,132,773 |
| Cost of Goods Sold | 2,447,241 | 2,468,259 |
| Gross Profit | 3,213,918 | 2,664,514 |
| Operating Expenses | ||
| Research and product development costs | 616,982 | 668,470 |
| Marketing and selling expenses | 1,024,984 | 858,151 |
| General and administrative costs | 674,792 | 654,525 |
| Total Operating Expenses | 2,316,758 | 2,181,146 |
| Operating Income | 897,160 | 483,368 |
| Interest and Dividend Income | 114,624 | 142,098 |
| Net unrealized (loss) on marketable securities | (26,271) | (21,923) |
| Income Before Income Taxes | 985,513 | 603,543 |
| Income Tax Expense | 244,345 | 118,558 |
| Net Income | 741,168 | 484,985 |
| Basic Earnings Per Share | 0.05 | 0.03 |
| Diluted Earnings Per Share | 0.05 | 0.03 |
| Weighted Average Shares Basic | 15,713,185 | 15,733,955 |
| Weighted Average Shares Diluted | 15,737,276 | 15,748,556 |
Condensed Consolidated Balance Sheets
| Description | May 31, 2026 (Unaudited) | February 28, 2026 |
|---|---|---|
| ASSETS | ||
| Current Assets: | ||
| Cash and cash equivalents | 8,982,075 | 7,339,403 |
| Marketable securities | 7,669,872 | 7,469,649 |
| Accounts receivable (less allowance of $12,225, respectively) | 1,264,932 | 3,350,953 |
| Inventories | 4,063,132 | 3,923,350 |
| Prepaid expenses and other current assets | 659,518 | 743,295 |
| Total current assets | 22,639,529 | 22,826,650 |
| Land | 250,000 | 250,000 |
| Buildings, equipment, furnishings and leasehold improvements, net | 2,138,226 | 2,173,443 |
| Intangible assets, net | 27,892 | 29,791 |
| Deferred tax asset | 809,182 | 1,141,611 |
| TOTAL ASSETS | 25,864,829 | 26,421,495 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current Liabilities: | ||
| Accounts payable | 935,442 | 1,038,885 |
| Accrued expenses | 2,088,229 | 2,227,401 |
| Customer deposits | 2,006,896 | 3,069,743 |
| Income taxes payable | 147,984 | 255,398 |
| Total current liabilities | 5,178,551 | 6,591,427 |
| Deferred tax liability | 75,238 | 55,909 |
| Total liabilities | 5,253,789 | 6,647,336 |
| Commitments and Contingencies (Note 10) | — | — |
| Stockholders’ Equity | ||
| Common stock, $.01 par value; 25,000,000 shares authorized, 15,716,723 and 15,710,389 issued and outstanding as of May 31, 2026 and February 28, 2026 | 157,167 | 157,104 |
| Additional paid-in capital | 10,282,508 | 10,186,858 |
| Accumulated earnings | 10,171,365 | 9,430,197 |
| Total stockholders’ equity | 20,611,040 | 19,774,159 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | 25,864,829 | 26,421,495 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Description | Three months ended May 31, 2026 | Three months ended May 31, 2025 |
|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net Income | 741,168 | 484,985 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 118,637 | 153,723 |
| Stock-based compensation expense | 85,825 | 75,163 |
| Inventory write-off | 56,671 | 98,585 |
| Unrealized loss on marketable securities | 26,271 | 21,923 |
| Deferred income tax benefit, net | 351,758 | (143,356) |
| (Increase) Decrease in: | ||
| Accounts receivable | 2,086,021 | (748,916) |
| Inventories | (196,453) | (373,515) |
| Prepaid expenses and other assets | 83,777 | (30,562) |
| (Decrease) Increase in: | ||
| Accounts payable | (103,443) | (159,011) |
| Accrued expenses | (139,172) | 129,444 |
| Customer deposits | (1,062,847) | (123,351) |
| Income taxes payable | (107,414) | (307,405) |
| Net Cash Provided by (Used in) Operating Activities | 1,940,799 | (922,293) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchase of equipment, furnishings and leasehold improvements | (81,521) | (52,249) |
| Sale of marketable securities | 299,774 | 1,364,134 |
| Purchase of marketable securities | (526,268) | (649,435) |
| Net Cash (Used in) Provided by Investing Activities | (308,015) | 662,450 |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Proceeds from exercise of stock options | 9,888 | — |
| Purchase of treasury stock | — | (79,479) |
| Net Cash Provided by (Used in) Financing Activities | 9,888 | (79,479) |
| NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS | 1,642,672 | (339,322) |
| CASH AND CASH EQUIVALENTS: | ||
| Beginning of period | 7,339,403 | 5,202,361 |
| End of period | 8,982,075 | 4,863,039 |
| Supplemental Cash Flow Disclosure: | ||
| Interest Paid | — | — |
| Income Taxes Paid | — | 569,319 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗